52% PAT Growth Masks the Quarter That Slowed Down
Year-over-year profit surged 52%, but sequential growth flatlined at 2.7%. Management's refusal to quantify forward guidance and shift of capex timelines into 'planning stage' signal caution. The quarter was real—but the momentum fade is what matters next.
51.8%
₹80.8 Cr delivered
2.7%
implies Q1 ≈ ₹78.6 Cr
25.8%
stable; +114 bps YoY
₹480 bps
partially offset by ₹360 bps savings
On paper, Manorama delivered a monster quarter: revenue ₹459 crore (+42% YoY), PAT ₹81 crore (+52% YoY), and EBITDA margin steady at 25.8%. But dig into the sequential numbers and the story flips. Quarter-on-quarter, PAT grew just 2.7%—which, when laid against the 52% YoY headline, signals that Q2 itself was a slowdown from Q1. The company's management response? Soften forward guidance from implicit 40%+ growth to directional 'good growth,' and push debottlenecking commissioning from Q3 FY27 to 'planning stage.' That divergence between the optics and the momentum is where this quarter lives.
Profit quality: freight headwinds offset by cost discipline
There are no major one-time gains or charges muddying the picture. The organic story is clean but macro-exposed: freight inflation (Red Sea disruptions, global shipping costs) hit Q2 to the tune of ₹480 basis points. Management offset roughly ₹360 bps through other cost savings and volume/price realization gains (management credited 85% volume growth, 10–15% price realization). Net result: a ₹120 bps structural headwind that management expects to normalize as global logistics stabilize. The ₹1,000 crore inventory pickup (from ₹728 crore in Q1) is entirely attributable to early West African shea procurement and new region entry; operating cash outflow of ₹252 crore in H1 is a timing issue, not a deterioration in cash generation. H2 should reverse it.
Q2 revenue ₹459 Cr, +41.9% YoY
₹458.9 Cr actual; YoY 41.9%
Supported — verbatim match
Q2 PAT ₹81 Cr, +51.8% YoY
₹80.8 Cr actual; YoY 51.8%
Supported — exact match
Plant utilization 85% on 47.5K ton capacity
Corroborated by delivered margin/volume metrics
Supported — no contrary evidence
Freight cost is the primary headwind, not RM inflation
₹480 bps cost elevation in Q2; external macro driver (Red Sea, shipping inflation)
Supported — management deflected raw-material link; analysts accepted
Capacities fully booked, no customer slowdown
QoQ PAT growth 2.7% suggests Q2 faced margin/volume pressure within quarter
Partially contradicted — bullish claim conflicts with sequential deceleration
What changed from prior guidance
Debottlenecking timeline slipped. On the Q1 FY27 call, management guided Q3 FY27 debottlenecking commissioning (4.5K MTPA). This call: 'Under planning, targeting Q3' (effectively pushed into design phase). Management cited design engineers in 'critical phase of completion' but offered no firm date. That's a soft miss on prior commitment. Growth guidance now directional, not quantified. Prior trajectory implied 40%+ FY27 growth. This call, analyst Utkarsh Somaiya pressed for explicit targets (40%/30%/20%). Management declined, stating it's about 'longer-term vision,' not hitting quarterly percentages. That defensive posture—after 52% YoY PAT growth—signals either macro caution or hedging high expectations. Value-added mix (CBE + stearin) improved. Now 70–75% of volumes, targeting 70–80% going forward. Higher-margin contribution per unit. This is genuine progress in mix and is tracking prior strategic goals. Freight cost disclosed explicitly. No longer buried; management owns the ₹480 bps headwind and attributed it to global logistics, not raw material inflation. That clarity is credible.
Record YoY growth (42% revenue, 52% PAT) is real
EBITDA margin stable at 25.8%; not margin-diluting
Balance sheet strengthened (ND/E 0.04x, cash ₹498 Cr); liquidity strong
Export diversification across 39 countries; geographic de-risking
Value-added mix (CBE/stearin 70–75%) improving; higher-margin trajectory
Sequential PAT growth flatlined at 2.7%; momentum visibly fading
Freight cost headwind ₹480 bps unresolved; macro-dependent normalization uncertain
Debottlenecking timeline slipped from Q3 FY27 to 'planning stage'; no firm date
Forward growth guidance softened from implicit 40%+ to directional 'good growth'; management deflecting specificity
₹1,000 Cr inventory and ₹252 Cr H1 operating cash outflow; working capital timing risk in H2
Freight cost normalization uncertain; global logistics remain volatile
MediumRed Sea disruptions, shipping inflation are external macro factors. ₹480 bps Q2 headwind persists until global supply chains stabilize. Management expects normalization but offers no timeline. If shipping costs remain elevated, the ₹120 bps net headwind (after cost offsets) becomes structural, capping margin upside.
Capex project execution and timeline slippage
MediumDebottlenecking moved from Q3 FY27 (prior) to 'planning stage' (now). Burkina Faso refinery and fractionation plants are complex; design phase ongoing. If commissioning timelines slip further, FY28 growth and capex ROI targets compress. Each quarter of delay is 25% of a typical quarterly ramp.
Sequential momentum fading within quarters
MediumQoQ PAT growth of 2.7% (vs 52% YoY) contradicts the 'fully booked' and 'healthy demand' narrative. It suggests Q2 itself faced headwinds. If Q3 also shows fading sequential growth, the YoY comparisons may be misleading the market; the organic run-rate would be weaker.
Raw material sourcing concentration in West Africa; geopolitical risk
MediumExpanded sourcing from West Africa (shea nuts, butters) for specialty fats; Burkina Faso project introduces sovereign risk (recent political instability, coups). Early procurement strategy (₹1K Cr inventory) reduces Q2–Q3 volatility but doesn't eliminate geopolitical tail risk. Regulatory changes or sanctions could disrupt supply.
Working capital normalization in H2 may not materialize
Low₹1,000 Cr inventory (up from ₹728 Cr Q1) and ₹252 Cr H1 operating cash outflow are attributed to timing (early shea procurement, new region entry). If customer demand softens or procurement continues, H2 may not reverse the working capital drain. Net debt could spike unexpectedly.
The street is positioned cautiously
The stock is trading ₹1,879.5 as of Nov 17, down 13% from its all-time high of ₹2,161 but above its 20-day simple moving average (₹1,877.74) and significantly above its 52-week low (₹1,060.6). It sits below the 50-day SMA (₹1,925.05), signaling that the recent drawdown has been real but not capitulation. RSI at 47.2 is neutral—no overbought or oversold extreme. Volume has been increasing, suggesting institutional participation. Ownership flows tell the story of guarded buying: FII ownership rose 94 basis points QoQ to 4.16% (Q2 FY27 vs Q1), and DII added 377 basis points to 6.40%. Promoters trimmed 294 basis points to 51.38%, a minor de-concentration. This mix—foreigners and domestic institutions accumulating while promoters modestly trim—is consistent with a company that has delivered strong numbers but whose forward outlook is uncertain. It's not a panic sell; it's repositioning. Bulk/block deals are neutral: a matched buy/sell of 3.54 lakh shares by MICROCURVES TRADING on Aug 14 at ₹1,779–₹1,781 appears to be an operational hedge, not an insider stake-build or dump. No promoter-linked selling near the highs.
Valuation context: The stock has staged a 77% rally off its 52-week low but is in a correction phase from the highs. The price action itself—a 13% drawdown from ATH after reporting 52% YoY PAT growth—reflects the market's own skepticism about the near-term momentum. The institution buying (FII/DII adding) is consistent with a 'quality at a discount' thesis, not euphoria.
1 · Q3 debottlenecking progress (by Dec 31)
Management must move debottlenecking from 'planning stage' to a firm timeline with design completion milestones. Any further delay signals execution risk on capex; any firm commissioning date (even if pushed to Q4 FY27 or Q1 FY28) would be credible progress and restore confidence in capex ROI.
2 · Q3 sequential PAT growth (Jan 2027 results)
If Q3 PAT grows >8–10% QoQ, momentum is re-accelerating and the Q2 slowdown was temporary (working capital/seasonal freight timing). If it's <5%, the thesis is that organic run-rate growth has decelerated and YoY comparisons are becoming easier. This single metric defines whether the company is re-accelerating or sustaining at a lower pace.
3 · Freight cost normalization (global logistics environment)
Red Sea/international shipping cost trends. If container rates and freight premiums normalize by Q3–Q4, the ₹120 bps headwind reverses into a tailwind, delivering ~100 bps margin upside. This is external but material; management's credibility on guidance hinges on this.
Manorama delivered exactly what it promised on the call—revenue ₹459 crore, PAT ₹81 crore, margins stable. That's credibility on earnings quality. But the story of this quarter is not the headline; it's the sequential slowdown (2.7% QoQ PAT growth), the guidance softening ('good growth,' unquantified), and the capex timeline vagueness (debottlenecking pushed to 'planning'). The YoY comparisons are easy because Q2 FY26 was weak; what matters is whether the company can re-accelerate from Q2's modest sequential pace.
This is a solid long-term story—capex magnitude, geographic expansion, mix improvement are all credible and tracking. But the near-term momentum is contested, and management's refusal to quantify forward guidance suggests caution. Freight normalization and capex execution will resolve the debate by Q3–Q4.
**Rating: Hold.** **The number to track: Q3 sequential PAT growth.** Above 10% QoQ signals re-acceleration and validates the bull thesis. Below 5% signals the organic run-rate has cooled. Everything else—freight, capex, inventory—flows from that single metric.
Informational and educational content only. Not investment advice.